Boots Owner Explores Potential $10 Billion Sale
UK health and beauty retailer Boots is in preliminary sale discussions with parties including Australian pharmacy giant Sigma Healthcare (owner of Chemist Warehouse) and the billionaire Weston family, in a deal reported to be worth between $10 billion and $14 billion. Boots is currently owned by private equity firm Sycamore Partners, which acquired it through its takeover of Walgreens Boots Alliance last year. A successful sale would rank among the largest UK retail transactions in recent years and could shelve plans for a London IPO of the 177-year-old chain.
Boots, the iconic 177-year-old UK pharmacy and health-and-beauty chain with approximately 1,800 stores, is in early-stage sale talks with multiple potential buyers, according to reports first published by the Financial Times. Sigma Healthcare, the ASX-listed parent of Chemist Warehouse following their 2025 merger, confirmed in a statement to the Australian Securities Exchange that it has engaged in 'preliminary discussions' regarding the sale process, while cautioning that no transaction is certain. The Weston family, a Canadian billionaire dynasty that owns grocery chain Loblaws and pharmacy chain Shoppers Drug Mart through Wittington Investments, is also reportedly involved in discussions. Sycamore Partners, the private equity firm that took control of Boots via its acquisition of Walgreens Boots Alliance, reportedly began approaching potential strategic buyers before Easter 2026. The reported deal value ranges from $10 billion (USD) to over $14 billion (AUD), with the discrepancy reflecting currency conversion differences across sources. Boots posted strong recent trading results, with comparable retail sales rising nearly 6% in the UK last year, driven by beauty and pharmacy growth including vaccinations and weight-loss treatments. If completed, the deal would likely end Sycamore's previously reported plans for a London stock market listing of Boots.
What's missing
It is unclear what valuation methodology underpins the reported price range, or whether Stefano Pessina — a major Boots shareholder — has a formal role or veto in any transaction.
How coverage differed
Bloomberg and Yahoo Finance reported the deal value in USD/GBP terms at approximately $10 billion/£7.5 billion, while the Sydney Morning Herald emphasized the AUD equivalent of over $14 billion and foregrounded Sigma Healthcare's Australian identity and prior UK expansion moves, reflecting its audience's interest in the story as a domestic business development.
What different sources said
- BloombergCenter
Boots in Talks About Possible $10 Billion Sale, FT Says
- Sydney Morning HeraldCenter
Chemist Warehouse owner eyes $14 billion deal for UK giant
- Yahoo FinanceCenter
Boots in £7.5bn sale talks with billionaire family behind Primark
Related
SpaceX IPO Makes Elon Musk World's First Trillionaire as Shares Surge 19% on Debut
SpaceX shares closed up 19% on their first trading day, pushing Elon Musk's net worth to approximately $1.11 trillion and making him the first individual in history to cross the trillion-dollar threshold. The company raised $75 billion at an IPO price of $135 per share, with shares closing near $161, giving SpaceX a market capitalization of roughly $2.1 trillion despite the company reporting a net loss of $4.94 billion in 2025. The milestone has drawn both investor enthusiasm and sharp criticism over Musk's social media conduct and concerns that the IPO's structure exploits passive index fund mechanics to extract wealth from ordinary retirement savers.
Delhi Power Bills to Rise for Some Consumers as Regulator Approves Higher Electricity Surcharge
Delhi's electricity regulator DERC has approved increased Power Purchase Adjustment Charges (PPAC) for distribution companies, raising bills for consumers in south, east, and central Delhi from July 2026. The hike follows a sharp rise in power procurement costs in April 2026, driven by higher summer demand and elevated fuel prices. The change also marks a structural shift from quarterly to monthly PPAC revisions, making electricity bills more responsive to real-time cost fluctuations.
SEC Proposes Repealing Rule 611 and Rule 610(e) of Regulation NMS
The Securities and Exchange Commission proposed on June 11, 2026, to rescind Rule 611 and Rule 610(e) of Regulation NMS, which govern trade-through protections and locking/crossing quotations in equity markets. Rule 611, in place for roughly two decades, requires trades to be executed at the best available price across exchanges. The proposal could reshape equity market structure and has implications for emerging areas such as tokenized stocks.